Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan E Bates

Showing results (61-70 of 293) with videos related to

Pageof 30
Sort By:
The Oncologist|January 20, 2021
Emergency Department Visits for Emesis Following Chemotherapy: Guideline Nonadherence, OP-35, and a Path Back to the FutureAlfred I Neugut, Susan E Bates
The Oncologist|October 25, 2018
Conflict of Interest: An Ethical Firestorm with Consequences for Cancer ResearchBruce A Chabner, Susan E Bates
The Oncologist|August 7, 2023
Highlights of ASCO 2023Alfred I Neugut, Susan E Bates
The Oncologist|March 27, 2014
Clinical trial results: a clinical trial bazaar!Antonio Tito Fojo, Susan E Bates
Cancer Journal (Sudbury, Mass.)|May 4, 2007
Histone deacetylase inhibitors in combinations: will the preclinical promises be kept?Susan E Bates, Richard L Piekarz
The Oncologist|April 24, 2016
Targeting Prolactin Receptor (PRLR) Signaling in PRLR-Positive Breast and Prostate CancerCiara C O'Sullivan, Susan E Bates
The Lancet. Neurology|April 25, 2006
Treatment of drug resistance in epilepsy: one step at a timeSanjay M Sisodiya, Susan E Bates
The Oncologist|June 8, 2022
Supreme Court and the Practice of OncologyBruce A Chabner, Susan E Bates
F1000 Biology Reports|October 16, 2010
PARP inhibitors in BRCA1/BRCA2 germline mutation carriers with ovarian and breast cancerChristina M Annunziata, Susan E Bates
The Oncologist|April 10, 2009
Commentary: troublesome words, linguistic precision, and medical oncologySusan E Bates, Edward J Benz
Pageof 30

Showing results (61-70 of 293) with videos related to

Sort By:
Pageof 30
The Oncologist|January 20, 2021
Emergency Department Visits for Emesis Following Chemotherapy: Guideline Nonadherence, OP-35, and a Path Back to the FutureAlfred I Neugut, Susan E Bates
The Oncologist|October 25, 2018
Conflict of Interest: An Ethical Firestorm with Consequences for Cancer ResearchBruce A Chabner, Susan E Bates
The Oncologist|August 7, 2023
Highlights of ASCO 2023Alfred I Neugut, Susan E Bates
The Oncologist|March 27, 2014
Clinical trial results: a clinical trial bazaar!Antonio Tito Fojo, Susan E Bates
Cancer Journal (Sudbury, Mass.)|May 4, 2007
Histone deacetylase inhibitors in combinations: will the preclinical promises be kept?Susan E Bates, Richard L Piekarz
The Oncologist|April 24, 2016
Targeting Prolactin Receptor (PRLR) Signaling in PRLR-Positive Breast and Prostate CancerCiara C O'Sullivan, Susan E Bates
The Lancet. Neurology|April 25, 2006
Treatment of drug resistance in epilepsy: one step at a timeSanjay M Sisodiya, Susan E Bates
The Oncologist|June 8, 2022
Supreme Court and the Practice of OncologyBruce A Chabner, Susan E Bates
F1000 Biology Reports|October 16, 2010
PARP inhibitors in BRCA1/BRCA2 germline mutation carriers with ovarian and breast cancerChristina M Annunziata, Susan E Bates
The Oncologist|April 10, 2009
Commentary: troublesome words, linguistic precision, and medical oncologySusan E Bates, Edward J Benz
Pageof 30